tiprankstipranks
Advertisement
Advertisement
Veru enrolls first patient in Phase 2b PLATEAU trial of enobosarm
PremiumThe FlyVeru enrolls first patient in Phase 2b PLATEAU trial of enobosarm
2M ago
Veru Inc. Charts Risky but Clearer Post-GLP-1 Path
Premium
Company Announcements
Veru Inc. Charts Risky but Clearer Post-GLP-1 Path
3M ago
Veru reports Q1 EPS (26c) vs. (61c) last year
Premium
The Fly
Veru reports Q1 EPS (26c) vs. (61c) last year
3M ago
Options Volatility and Implied Earnings Moves This Week, December 15 – December 19, 2025
PremiumMarket NewsOptions Volatility and Implied Earnings Moves This Week, December 15 – December 19, 2025
5M ago
Is VERU a Buy, Before Earnings?
Premium
Pre-Earnings
Is VERU a Buy, Before Earnings?
5M ago
Veru Announces Public Offering to Raise $23.4 Million
Premium
Company Announcements
Veru Announces Public Offering to Raise $23.4 Million
6M ago
Veru Settles Debt with Onconetix Agreement
PremiumCompany AnnouncementsVeru Settles Debt with Onconetix Agreement
8M ago
Onconetix announces financing through private placement, debt settlement
Premium
The Fly
Onconetix announces financing through private placement, debt settlement
8M ago
Veru announces FDA meeting providing regulatory clarity for Enobosarm
Premium
The Fly
Veru announces FDA meeting providing regulatory clarity for Enobosarm
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100